Tech Company Financing Transactions

TARIS Biomedical Funding Round

TARIS Biomedical, based in Lexington, secured $25 million in funding from Yonghua Capital, Bristol-Myers Squibb and Flagship Pioneering.

Transaction Overview

Company Name
TARIS Biomedical
Announced On
12/22/2017
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors

Yonghua Capital (Lead Investor) (Moses Zhao)

Bristol-Myers Squibb

Flagship Pioneering (Ed Kania)

private investors (Roman Abramovich)

Norma Investments

Polaris Partners (Kevin Bitterman)

RA Capital (Rajeev Shah)

Proceeds Purpose
Both programs demonstrate our unique approach to designing novel therapeutics that may dramatically change the management of these serious diseases. Funds from this round will be used to rapidly advance both indications through key clinical milestones.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
113 Hartwell Ave.
Lexington, MA 02421
USA
Phone
(781) 676-7750
Website
www.tarisbiomedical.com
Email Address
[email protected]
Overview
TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products.
Profile
TARIS Biomedical LinkedIn Company Profile
Social Media
TARIS Biomedical Company Twitter Account
Company News
TARIS Biomedical News
Facebook
TARIS Biomedical on Facebook
YouTube
TARIS Biomedical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tony Kingsley
  Tony Kingsley LinkedIn Profile  Tony Kingsley Twitter Account  Tony Kingsley News  Tony Kingsley on Facebook
Chief Financial Officer
Diane Marcou
  Diane Marcou LinkedIn Profile  Diane Marcou Twitter Account  Diane Marcou News  Diane Marcou on Facebook
Chief Medical Officer
Christopher Cutie
  Christopher Cutie LinkedIn Profile  Christopher Cutie Twitter Account  Christopher Cutie News  Christopher Cutie on Facebook
Chief Scientific Officer
Dennis Giesing
  Dennis Giesing LinkedIn Profile  Dennis Giesing Twitter Account  Dennis Giesing News  Dennis Giesing on Facebook
Chief Technical Officer
Cheryl Larrivee-Elkins
  Cheryl Larrivee-Elkins LinkedIn Profile  Cheryl Larrivee-Elkins Twitter Account  Cheryl Larrivee-Elkins News  Cheryl Larrivee-Elkins on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/22/2017: Nylas venture capital transaction
Next: 12/22/2017: FLX Bio venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.